BETA

16 Amendments of Ádám KÓSA related to 2016/0130(COD)

Amendment 9 #
Proposal for a directive
Recital -1 (new)
(-1) Directive 2004/37/EC expresses the position reached by the relevant scientific and expert committees of the European Union, taking into account the opinions of international scientific bodies, as well as the position debated and adopted by the Member States’ experts; the requirements both of precise research and of majority approval are met.
2016/12/09
Committee: JURI
Amendment 12 #
Proposal for a directive
Recital 1 a (new)
(1a) Carcinogens, mutagens and reprotoxic substances differ significantly from the point of view of their characteristics, impact, the persons affected and the quantity of scientific data available.
2016/12/09
Committee: JURI
Amendment 16 #
Proposal for a directive
Recital 2
(2) The limit values should be revised when necessary in the light of scientific data, but the changes must be introduced within 2 years of the entry into force of this Directive, having regard to the long – 5-year – reporting cycle and the opportunities for amendment.
2016/12/09
Committee: JURI
Amendment 19 #
Proposal for a directive
Recital 2 a (new)
(2a) It is necessary to highlight the importance of protecting workers against exposure to carcinogens, mutagens and substances that are toxic to reproduction. In the workplace, men and women are often exposed to a mixture of substances, which can increase health risks, cause adverse effects on their reproductive systems, impaired fertility or infertility, and also have a negative impact on foetal development.
2016/12/09
Committee: JURI
Amendment 21 #
Proposal for a directive
Recital 2 b (new)
(2b) The danger posed by carcinogens is not dependent on age or gender but is the same for all workers, namely the risk of developing a tumour; on the other hand, the spectrum of damaging impacts of reprotoxic substances is broader; they may harm the sexual functioning and/or fertility of one, the other or both genders and/or the development of their children, but the risks also include harmful impacts on lactation or harm inflicted through lactation.
2016/12/09
Committee: JURI
Amendment 23 #
Proposal for a directive
Recital 2 c (new)
(2c) The Directive names those carcinogens for which, on the basis of the available scientific data and the positions adopted by national scientific bodies and the scientific bodies of some Member States, occupational exposure limits may be set which reflect a known – and acceptable – risk, and Annex III to the Directive contains a list of the currently established occupational exposure limits which it is compulsory to introduce, adopted with the consensus of the Member States.
2016/12/09
Committee: JURI
Amendment 28 #
Proposal for a directive
Recital 3 a (new)
(3a) Protecting workers is also an important issue, and in the case of certain substances regulation must take into account the gender of the worker and, in the case of women, their age (reproductive age) and physiological condition (pregnancy, breastfeeding). Protection against reprotoxic substances requires a more comprehensive approach than protection against carcinogens. In the case of reprotoxic substances, it is also very important to set appropriate limits on occupational exposure. In the case of most reprotoxic substances, an exposure level (health-based limit value) can be established below which no harm is to be expected, but not for example in the case of endocrine disrupters. It may be justified to set two limit values for some substances (for women of reproductive age and for other workers). In the case of reprotoxic substances, far less human epidemiological data is currently available than in the case of carcinogens, but knowledge is likely to increase because interest has increasingly been focused on these substances.
2016/12/09
Committee: JURI
Amendment 30 #
Proposal for a directive
Recital 3 b (new)
(3b) Reprotoxic substances which are simultaneously carcinogens/mutagens at all events fall under Directive 2004/37/EC, and only binding occupational exposure limit values (BOELVs) are possible for them.
2016/12/09
Committee: JURI
Amendment 36 #
Proposal for a directive
Recital 1 a (new)
(1a) Directive 2004/37/EC expresses the position reached by the relevant scientific and expert committees of the European Union, taking into account the opinions of international scientific bodies, as well as the position debated and adopted by the Member States’ experts; the requirements both of precise research and of majority approval are met.
2017/01/12
Committee: EMPL
Amendment 38 #
Proposal for a directive
Recital 1 b (new)
(1b) Account must be taken of the fact that carcinogens, mutagens and reprotoxic substances differ significantly from the point of view of their characteristics, impact, the persons affected and the quantity of scientific data available, and it is therefore desirable to lay down requirements and regulations concerning reprotoxic substances in a separate directive.
2017/01/12
Committee: EMPL
Amendment 44 #
Proposal for a directive
Recital 21 a (new)
(21a) Calls upon the Commission to submit a proposal for the adoption of a special directive on defending workers against reprotoxic substances, which should also contain occupational exposure limit values (IOELVs).
2016/12/09
Committee: JURI
Amendment 45 #
Proposal for a directive
Recital 2 a (new)
(2a) Account must be taken of the fact that the danger posed by carcinogens is not dependent on age or gender but is the same for all workers, namely the risk of developing a tumour; on the other hand, the spectrum of damaging impacts of reprotoxic substances is broader; they may harm the sexual functioning and/or fertility of one, the other or both genders and/or the development of their children, but the risks also include harmful impacts on lactation or harm inflicted through lactation.
2017/01/12
Committee: EMPL
Amendment 48 #
Proposal for a directive
Recital 2 a (new)
(2a) The European Commission should examine whether Directive 2004/37/EC should still be amended to strengthen health surveillance. Due to the lack of consistent data on substance exposure, it is necessary to protect exposed workers or workers who are at risk of exposure.
2017/01/12
Committee: EMPL
Amendment 52 #
Proposal for a directive
Annex
0,02501
2016/12/09
Committee: JURI
Amendment 55 #
Proposal for a directive
Recital 2 b (new)
(2b) The European Commission should examine how appropriate and consistent data collection can be performed by Member States from employers to improve and ensure safety and proper care for workers.
2017/01/12
Committee: EMPL
Amendment 78 #
Proposal for a directive
Recital 6 a (new)
(6a) Protecting workers is also an important issue, and in the case of certain substances regulation must take into account the gender of the worker and, in the case of women, their age (reproductive age) and physiological condition (pregnancy, breastfeeding). Protection against reprotoxic substances requires a more comprehensive approach than protection against carcinogens. In the case of reprotoxic substances, it is also very important to set appropriate limits on occupational exposure. In the case of most reprotoxic substances, an exposure level (health-based limit value) can be established below which no harm is to be expected, but not for example in the case of endocrine disrupters. It may be justified to set two limit values for some substances (for women of reproductive age and for other workers). In the case of reprotoxic substances, far less human epidemiological data is currently available than in the case of carcinogens, but knowledge is likely to increase because interest has increasingly been focused on these substances.
2017/01/12
Committee: EMPL